SOLICITATION NOTICE
B -- Notice of Intent: In vitro cell permeation model and drug classification for the prediction of drug transfer into human milk
- Notice Date
- 6/14/2019
- Notice Type
- Synopsis
- NAICS
- 541690
— Other Scientific and Technical Consulting Services
- Contracting Office
- 4041 Powder Mill Road Beltsville MD 20705
- ZIP Code
- 20705
- Solicitation Number
- FDA-19-NOI-1214177
- Response Due
- 6/29/2019
- Point of Contact
- Christopher R. McGucken, Contract Specialist, Phone (240) 402-7566
- E-Mail Address
-
christopher.mcgucken@fda.hhs.gov
- Small Business Set-Aside
- N/A
- Description
- This synopsis is hereby issued in accordance with FAR Part 5.203 and FAR 13.501(a) in response to the mandatory requirement for a 15-day notification. The purpose of this synopsis is to announce the Food and Drug Administration's (FDA) intent to negotiate a Firm Fixed Price sole source contract with Husson University- School of Pharmacy., located at 1 College Circle, Bangor, Maine 04401 to develop and validate a human mammary epithelial permeability assay and use in vitro to in vivo extrapolation (IVIVE) approach to predict the amount of drug transfer into human milk. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (14-JUN-2019); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT 877-472-3779 or fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link To Document
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-19-NOI-1214177/listing.html)
- Record
- SN05340972-F 20190616/190614230014 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |